A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis

Tipo: Article

Colaboración

Año: 2021

Autores

Jimenez-Morales, A; Caliz, R; Aceituno, S; Prades, M; Blanch, C

Revista

Título: REUMATOLOGIA CLINICA